Mechanism of triterpenoids from Alismatis Rhizoma against liver fibrosis based on an integrated approach using network pharmacology, molecular docking, and luciferase assay

被引：0
|
作者：
Zhang, Yi [1 ,2 ,3 ]
Jiang, Kaiyuan [1 ,2 ]
Liu, Pei [1 ,2 ]
Tang, Yingying [1 ,2 ]
Li, Guancheng [4 ]
Xiong, Aizhen [1 ,2 ,3 ]
Yang, Li [1 ,2 ,3 ]
Wang, Zhengtao [1 ,2 ,3 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, SATCM Key Lab New Resources & Qual Evaluat Chinese, Shanghai, Peoples R China
[3] Shanghai R&D Ctr Standardizat Tradit Chinese Med, Shanghai, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Peoples Hosp 6, Shanghai, Peoples R China
来源：
NATURAL PRODUCT RESEARCH | 2023年 / 37卷 / 22期
关键词：
Alismatis Rhizoma triterpenoids; liver fibrosis; network pharmacology; molecular docking; luciferase assay; farnesoid X receptor; ALISOL B 23-ACETATE; NONALCOHOLIC STEATOHEPATITIS; MEDIATED REGULATION; FXR; TRANSPORTERS; CHOLESTASIS; PROTECTS; ENZYMES; ACID; MICE;
D O I：
10.1080/14786419.2022.2149520
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
Protostane-type triterpenoids are antifibrotic nature components with unique structures in Alismatis Rhizoma. However, the underlying mechanisms of them against liver fibrosis are not well illustrated. The present study aims to study the targets and mechanisms of Alismatis Rhizoma triterpenes responsible for their antifibrotic effects by network pharmacology, molecular docking, and luciferase assay. As a result, six molecular targets responsible for the antifibrotic effects of alisols against liver fibrosis were uncovered by network pharmacology, among which the activation of farnesoid X receptor (FXR/NR1H4) was highlighted and further confirmed by molecular docking and luciferase assay. Our present study provides a scientific basis for treating liver fibrosis by using Alismatis Rhizoma, especially via the FXR activation effects of alisols.
引用
收藏
页码：3826 / 3831
页数：6
相关论文
共 50 条
  • [31] Exploring molecular mechanism of Panlongqi Tablet (PLQT) against RA: Integrated network pharmacology, molecular docking and experiment validation
    Song, Huixin
    Yu, Jinjin
    Yang, Yajie
    Zhou, Lili
    Liu, Xinyao
    Yu, Jiabao
    Huang, Qiuxia
    Wang, Siqi
    Zhang, Xinya
    Liu, Yang
    Zhang, Dezhu
    Meng, Jianguo
    Han, Tengfei
    Li, Weifeng
    Niu, Xiaofeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 144
  • [32] Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach
    Dixit, Nandan
    Motwani, Harsha
    Patel, Saumya K.
    Rawal, Rakesh M.
    Solanki, Hiteshkumar A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (19): : 10237 - 10255
  • [33] Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking
    Lee, A. Yeong
    Lee, Joo-Youn
    Chun, Jin Mi
    PLANTS-BASEL, 2020, 9 (12): : 1 - 21
  • [34] An Integrated Approach of Network Based System Pharmacology Approach and Molecular Docking to Explore Multiscale Role of Pinus roxburghii and Investigation into its Mechanism
    Omer, Ankur
    Singh, Poonam
    PHARMACOGNOSY MAGAZINE, 2020, 16 (05) : S578 - S583
  • [35] Exploring the potential pharmacological mechanism of aripiprazole against hyperprolactinemia based on network pharmacology and molecular docking
    Yang, Lei
    Zhang, Qiuyu
    Li, Chao
    Tian, Hongjun
    Zhuo, Chuanjun
    SCHIZOPHRENIA, 2024, 10 (01)
  • [36] RESEARCH ON THE MECHANISM OF "XIYANGSHEN-SANQI" AGAINST ATHEROSCLEROSIS BASED ON NETWORK PHARMACOLOGY AND MOLECULAR DOCKING
    Duan, Kaixuan
    Cao, Shan
    Nie, Xingyuan
    Maxwell, Ahiafor
    Wang, Yanxi
    Xie, Sha
    Yang, Xuewei
    MEDICINE, 2023, 102 (03)
  • [37] Network pharmacology and molecular docking-based systemic approach to investigate the mechanism and molecular targets of phloridzin against Alzheimer's disease
    Aiswarya, G. Nambiyar
    Brindha, Durairaj
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2024, 19 (06): : 127 - 136
  • [38] Network Pharmacology Combined with Molecular Docking Approach to Investigate the Mechanism of ChuShiWeiLing Decoction Against Perianal Eczema
    Liu, Ying
    Hao, Min
    Fang, Xinyue
    Qian, Yifei
    Wang, Yahui
    Yan, Shuai
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (18) : 1442 - 1458
  • [39] Mechanism of Polygonum capitatum intervention in pulmonary fibrosis based on network pharmacology and molecular docking technology: A review
    Fan, Zhiliang
    Pu, Xiang
    Li, Lailai
    Li, Qian
    Jiang, Te
    Lu, Liping
    Tang, Jingwen
    Pan, Mei
    Zhang, Liyan
    Chai, Yihui
    MEDICINE, 2023, 102 (37) : E34912
  • [40] Network Pharmacology Integrated Molecular Docking Revealed the Mechanism of Jianpi Yiqi Taohua Decoction Against Ulcerative Colitis
    Jia, Lin
    Zhou, Haiyan
    Li, Wenhao
    Lv, Zhantai
    MEDICAL SCIENCE MONITOR, 2022, 28
12345